Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIS416 in chronic progressive multiple sclerosis
NCT01191996Phase 2Completed
- Sponsor
- Amplia Therapeutics Limited
- Start
- Aug 2010
- Primary completion
- Jun 2012
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of mis416 in multiple sclerosis (MS), sponsored by Amplia Therapeutics Limited. Started Aug 2010; status: completed.
02
Drugs
mis416
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01191996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01191996.